- Home
- QSI vs CRMD Comparison
QSI vs CRMD Comparison
Compare QSI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- CRMD
- Stock Information
- Founded
- QSI 2013
- CRMD 2006
- Country
- QSI United States
- CRMD United States
- Employees
- QSI N/A
- CRMD N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- QSI Health Care
- CRMD Health Care
- Exchange
- QSI Nasdaq
- CRMD Nasdaq
- Market Cap
- QSI 219.8M
- CRMD 973.3M
- IPO Year
- QSI N/A
- CRMD 2010
- Fundamental
- Price
- QSI $2.11
- CRMD $11.40
- Analyst Decision
- QSI Strong Buy
- CRMD Strong Buy
- Analyst Count
- QSI 3
- CRMD 7
- Target Price
- QSI $2.38
- CRMD $17.33
- AVG Volume (30 Days)
- QSI 8.4M
- CRMD 2.5M
- Earning Date
- QSI 08-06-2025
- CRMD 08-13-2025
- Dividend Yield
- QSI N/A
- CRMD N/A
- EPS Growth
- QSI N/A
- CRMD N/A
- EPS
- QSI N/A
- CRMD 0.28
- Revenue
- QSI $3,443,000.00
- CRMD $82,553,827.00
- Revenue This Year
- QSI $77.57
- CRMD $238.38
- Revenue Next Year
- QSI $251.34
- CRMD $53.52
- P/E Ratio
- QSI N/A
- CRMD $41.86
- Revenue Growth
- QSI 167.94
- CRMD N/A
- 52 Week Low
- QSI $0.61
- CRMD $3.61
- 52 Week High
- QSI $5.77
- CRMD $17.43
- Technical
- Relative Strength Index (RSI)
- QSI 65.03
- CRMD 39.52
- Support Level
- QSI $1.87
- CRMD $12.14
- Resistance Level
- QSI $2.14
- CRMD $17.43
- Average True Range (ATR)
- QSI 0.14
- CRMD 0.69
- MACD
- QSI 0.02
- CRMD -0.51
- Stochastic Oscillator
- QSI 93.65
- CRMD 4.60
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.